These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Therapeutic follow-up of cyclosporine. Main factors involved in the interpretation of results]. Cheymol G. Therapie; 1992 Aug; 47(4):319-21. PubMed ID: 1494795 [Abstract] [Full Text] [Related]
6. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W. Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391 [Abstract] [Full Text] [Related]
8. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA. Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259 [Abstract] [Full Text] [Related]
9. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C. Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691 [Abstract] [Full Text] [Related]
10. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine. Hoyer PF, Vester U. Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336 [Abstract] [Full Text] [Related]
11. [Cyclosporine microemulsion C2 monitoring in Chinese adult liver transplant recipients: a preliminary randomized control trial]. Chen G, He Y, Wang HZ, Lu Q, Yang SZ, Yang ZY, Dong JH. Zhonghua Wai Ke Za Zhi; 2005 Oct 01; 43(19):1243-7. PubMed ID: 16271221 [Abstract] [Full Text] [Related]
12. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation]. Blanchet B. Ann Pharm Fr; 2008 Mar 01; 66(2):96-101. PubMed ID: 18570908 [Abstract] [Full Text] [Related]
13. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine. Halim MA, Nampoory MR, Johny KV, Donia F, Hamid MH, Said T, Nair MP, Mansour M, Al-Muzairai I, Samhan M, Al-Mousawi M. Transplant Proc; 2005 Sep 01; 37(7):3019-21. PubMed ID: 16213291 [Abstract] [Full Text] [Related]
14. Optimization of cyclosporine for liver transplantation. Lilly LB, Grant D. Transplant Proc; 2004 Mar 01; 36(2 Suppl):267S-270S. PubMed ID: 15041351 [Abstract] [Full Text] [Related]
15. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K. Transplantation; 2008 Jan 27; 85(2):179-84. PubMed ID: 18212621 [Abstract] [Full Text] [Related]
17. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P. Nephrol Dial Transplant; 2006 Jan 27; 21(1):197-202. PubMed ID: 16204301 [Abstract] [Full Text] [Related]
19. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. Oellerich M, Armstrong VW, Streit F, Weber L, Tönshoff B. Clin Biochem; 2004 Jun 27; 37(6):424-8. PubMed ID: 15183289 [Abstract] [Full Text] [Related]